The Trump administration on Wednesday unveiled a sweeping new initiative aimed at modernizing the nation’s healthcare data infrastructure by enabling Americans to access and share their medical records through apps and services developed by private tech companies. While officials hailed the plan as a major step toward improved patient outcomes and efficiency, digital privacy experts expressed concern about how sensitive health information might be used—or misused—outside existing regulatory protections.
Announcing the effort at a White House event, President Donald Trump described the initiative as long overdue. “For decades, America’s health care networks have been overdue for a high-tech upgrade, and that’s what we are doing,” he said.
More than 60 companies—including tech giants Amazon, Apple, Google, and OpenAI—have pledged to participate in building what the administration describes as a “next-generation digital health ecosystem,” according to a statement from the Centers for Medicare & Medicaid Services (CMS). The goal is to make health records easily transferable between providers and accessible to patients, potentially reducing paperwork and improving care.
Initial use cases include digital check-in systems, AI-powered wellness apps for diabetes and obesity, and conversational assistants that help manage chronic conditions. The plan is also closely tied to the administration’s broader “Making America Healthy Again” agenda. In June, Health and Human Services Secretary Robert F. Kennedy Jr. told Congress he envisions every American using health-monitoring wearables within four years.
Yet the rollout has sparked immediate scrutiny from privacy advocates. Critics warn that companies not bound by the Health Insurance Portability and Accountability Act (HIPAA) could gain access to data once protected under strict federal standards.
“There are real questions about how patient data will be handled once it moves outside of HIPAA-covered entities,” said Andrew Crawford, a senior policy counsel at the Center for Democracy and Technology. “Will it be sold to advertisers? Will it be shared with law enforcement or used for unrelated surveillance?”
Crawford pointed to concerns about reproductive health data and location tracking—especially in a post-Roe environment—saying the initiative could unintentionally expose patients’ private medical choices.
CMS has promised the program will use “secure digital identity credentials” and emphasized that the system will be more personalized and secure than existing models. Still, even supporters of the plan acknowledge there are gaps to be addressed.
Dr. Brian Anderson, CEO of the Coalition for Health AI, said clear guidelines must be established to ensure patients understand how their data is being used. “We just need to come together—private and public sector—to define the rules of the road,” he said.
Despite the administration’s confidence, skeptics say the benefits for patients remain uncertain. “There are already mechanisms to share data securely,” Crawford noted. “The issue isn’t always access—it’s trust and accountability.”
The initiative is expected to roll out in phases later this year.